JAK2 and cancer: Similarly, Janus Kinase 2 (JAK2) inhibitor, which can modify the stroma, also decreased PD-L1 expression and enhanced the anti-cancer treatment as demonstrated in in vitro cancer cells (Wörmann et al. 2016; Doi et al. 2017)].